# Study of Capecitabine to Treat Recurrent High Grade Gliomas

> **NCT00717197** · PHASE2 · COMPLETED · sponsor: **University of Florida** · enrollment: 30 (actual)

## Conditions studied

- Malignant Glioma

## Interventions

- **DRUG:** Capecitabine

## Key facts

- **NCT ID:** NCT00717197
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2012-03
- **Final completion:** 2013-05
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2013-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00717197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00717197, "Study of Capecitabine to Treat Recurrent High Grade Gliomas". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00717197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*